Taiyo Recalls 178,000 Injection Kits Due To Anaphylaxis Reaction
This article was originally published in PharmAsia News
Executive Summary
Nagoya-based Taiyo Pharmaceutical Feb. 2 started recalling 178,650 Tetipline (saccharated ferric oxide) 40mg intravenous injection kits